Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
View corresponding page on italian website CURASEPT.IT
Home
Curasept Drymouth

Discover the products

Dry mouth is a condition in which salivary flow is reduced to a greater or lesser extent, either temporarily or permanently.

As a result of reduced salivary flow, several issues may occur: difficulty in forming the food bolus (the first stage of the digestive process), increased wear of dental tissues, reduced taste perception, difficulty swallowing, speaking, and wearing dentures, frequent interruptions of night-time rest due to the need to drink, and reduced lubrication of the mucous membranes. In the long term, this condition may lead to mucosal lesions, tooth decay, gingivitis, periodontitis, and candidiasis.

Therefore, dry mouth is a condition that should not be underestimated!

The causes of dry mouth can be multiple:

Side effects of certain medications

Known as xerogenic medications, which reduce salivary secretion*

Chemotherapy/radiotherapy

Applied to areas where salivary glands are present (e.g. head and neck)

Aging

Diabetes

Neuropsychiatric disorders

Autoimmune diseases such as Sjögren’s syndrome

Nasal airway obstruction and sleep apnea

Viral diseases

stress

HIV and HCV viral infections

*(approximately 500, including tricyclic antidepressants, antipsychotics, benzodiazepines, anticholinergic antiparkinsonian drugs, antihypertensives, diuretics, antihistamines, antidiarrheals, analgesics, and non-steroidal anti-inflammatory drugs)

Symptoms depend on the severity of the dry mouth sensation.

MILD (xerostomia) and MODERATE (hyposalivation)

  • “Foamy” or thick saliva
  • Uncomfortable friction between oral tissues
  • Localized burning sensation at the tip of the tongue or widespread burning sensation
  • Dry lips
  • Need to drink more frequently, especially during the night or to help swallow food more easily
  • Alterate taste perception
  • Coated tongue
  • Halitosis

SEVERE (asialia)

  • Intense and widespread burning sensation in the mouth
  • Difficulty chewing and swallowing solid and dry foods
  • Adherence of debris and food residues to teeth and oral mucosa
  • Difficulty wearing dentures and speaking
  • Night-time drying of the oral mucosa
  • Adhesion between hard dental tissues and oral mucosa
  • Frequent awakenings to drink
  • Atrophic tongue dorsum with fissures

The formulations of the Curasept Drymouth line have been developed to provide relief for users experiencing different conditions associated with reduced salivary flow.

Thanks to its formula enriched with MHS (Mouth Hydration System), a balanced blend of moisturising ingredients, particularly vitamin E, Curasept Drymouth provides an immediate and long-lasting feeling of comfort in the oral cavity, especially in cases of dryness.

This complete line consists of 5 products. Each product has been designed to meet different treatment needs and clinical conditions of patients.

Features and benefits of the Curasept Drymouth line thanks to its innovative formula:

icona gocce per azione stimolante

SALIVA-STIMULATING, MOISTURISING AND HYDRATING ACTION

The tablets, thanks to the patented FizzFRAPTech® technology, stimulate salivation, helping to maintain the hydration of the mucous membranes.

BIO-ADHESIVE AND PROTECTIVE ACTION

The barrier effect protects the oral mucosa from irritation and bacterial aggression caused by dryness, while also helping to maintain hydration.

ANTI-PLAQUE ACTION

Counteracts the proliferation of plaque-causing bacteria, reducing the risk of tooth decay.

pH CONTROL

The Phosphate Buffer system helps maintain pH at physiological levels, protecting against demineralisation.

REMINERALISING ACTION

Thanks to the presence of Fluoride (in the toothpaste).

ORAL MICROBIOTA BALANCE

The Postbiotic present in the gel helps counteract the presence of bacteria responsible for periodontal disease.

GENTLE ON THE MUCOSA

It does not contain irritating substances such as parabens, alcohol, and SLS (Sodium Lauryl Sulfate).

MILD AND PLEASANT FLAVOUR

For daily use, several times a day.

DISCOVER ALL THE BRANDS

THE FIRST NON-STAINING CHLORHEXIDINE

The first Curasept mouthwashes and toothpastes with Chlorhexidine featuring A.D.S.® – Anti Discoloration System, an innovative, patented, and clinically tested system that reduces the appearance of yellow-brown spots on the teeth, which is the main side effect of Chlorhexidine.

A.D.S.® inhibits the two chemical reactions leading to pigmentation, without affecting the antiplaque activity of Chlorhexidine. 

Curasept ADS

punto elenco blu e azzurro, nei colori inconfondibili del brand Curasept

Vuoi accedere ai contenuti Extra? Registrati o fai Login per accedere ai contenuti a te dedicati: articoli, video ,schede… e tanto altro!

Non ricordi la password?

Non sei registrato?
Clicca il pulsante qui sotto. La registrazione è gratuita.

Registrazione

Quality Policy

The Quality for CURASEPT S.p.A. is an essential condition to put itself successfully on the market, considering its characteristics and evolution.

The development of the Company and its profit are insured by the continuous search for quality towards excellence through the continuous improvement of its processes and the search for partners with quality systems adapted to our standards.

The Company aims to increase the customer satisfaction through the application of its Quality Management System, including the processes to improve the system and to ensure the compliance with the customer and applicable regulatory requirements.

For this purpose, the Company performs specific risks and opportunities assessment activities, connected to the context, stakeholders and related objectives, in order to identify the areas of system improvements and to define the appropriate actions for the risk control and mitigation and strengthening of its Quality System.

The starting point for the implementation of this policy is the pursuit of the following objectives:

  • Define and implement a Quality Management System according to 9001:2015+A1:2024 e UNI CEI EN ISO 13485:2021 regulation, as Manufacturer of Medical Devices;
  • Define and implement a system of procedures and operating instructions in harmony with the Directive 93/42/CEE, the Regulation (UE) 2017/745 and the Regulation (UE) 2023/607 for the applicable parts and subsequent changes and integrations, which satisfy the essential requirements set out in Annex I;
  • Define and implement a system of procedures in harmony with the Directive 2010/84, the Regulation 1235/2010, the Implementation Regulation n. 520/2012 and in accordance with the objectives of “module I – “Good Vigilance Practices” (GVP).
  • Define and implement, in collaboration with Outsourcers, a quality system and procedures to meet the regulatory requirements for the production of Cosmetics and Food Supplements.
  • Establish and formalize the business organizational structure with the subdivision into areas of competences;
  • Clarify roles and responsibilities of business functions;
  • Define strategies and objectives and assign human and material resources for their achievement;
  • Define accurately business processes and related performance factors;
  • Ensure compliance with qualitative, quantitative and temporal requirements;
  • Constantly monitor the level of adequacy of the system with reference to regulations and laws;
  • Promote initiatives in order to improve the process of motivational and professional growth of human resources, considered as critical resources for future business developments;
  • Ensure the commitment to the satisfaction of requirements and the maintenance of effectiveness of the Quality Management System.

These objectives can be realized thanks to the involvement of the whole Company personnel.

In particular, the Managers of each Function provide their contribution so that the suggested improvements can be proposed to the General Direction, so that the Quality Policy can be a priority element in the choice of business qualitative and organizational strategies.

The involvement of the whole personnel in the improvement of internal and external processes should be aimed at reducing non-compliance and internal and external costs of non-quality; for this reason all employees should feel themselves committed in pursuing this policy.

Training courses, for all business levels, are promoted and planned by the General Direction in order to keep the personnel constantly up to date on the improvements performed for the processes.

The Quality Manual, which is distributed via the SistemaQualità to all process managers and the General Director, should represent a work tool for all Managers and their personnel for the implementation of the Quality Policy.

May 2026

General Direction